Literature DB >> 19428073

Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis.

Andrea Tasca1, Luca Dalle Carbonare, Filippo Nigro, Sandro Giannini.   

Abstract

In patients affected by calcium nephrolithiasis, primary hypercalciuria is frequently accompanied by bone demineralisation and increased susceptibility to fragility fractures. The relationship between bone loss and primary hypercalciuria is multifactorial. Organs and tissues which control calcium and phosphate metabolism - bone, intestine, and kidney - are actively involved in the pathogenesis of bone alterations which together form a multi-factorial metabolic disorder. We conducted a comprehensive evaluation of the published data concerning hypercalciuria and nephrolithiasis included in Medline from 1985 and 2005.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428073     DOI: 10.1016/j.urology.2008.11.014

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria.

Authors:  Augusto C S Santos; Eleonora M Lima; Maria Goretti M G Penido; Katia D Silveira; Mauro M Teixeira; Eduardo A Oliveira; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-01-07       Impact factor: 3.714

2.  Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.

Authors:  Austin C Luskin; Jody P Lulich; Sarah C Gresch; Eva Furrow
Journal:  Res Vet Sci       Date:  2019-01-04       Impact factor: 2.534

Review 3.  Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.

Authors:  P Lucato; C Trevisan; B Stubbs; B M Zanforlini; M Solmi; C Luchini; G Girotti; S Pizzato; E Manzato; G Sergi; S Giannini; M Fusaro; N Veronese
Journal:  Osteoporos Int       Date:  2016-06-11       Impact factor: 4.507

Review 4.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

5.  Nephrolithiasis and Osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B.

Authors:  Jueying Lin; Yufeng Zhuo; Dongdong Zhang
Journal:  BMC Nephrol       Date:  2017-08-29       Impact factor: 2.388

Review 6.  Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.

Authors:  Daniel A Wollin; Adam G Kaplan; Glenn M Preminger; Pietro Manuel Ferraro; Antonio Nouvenne; Andrea Tasca; Emanuele Croppi; Giovanni Gambaro; Ita P Heilberg
Journal:  Asian J Urol       Date:  2018-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.